

Although neurons execute a cell intrinsic program of axonal growth during development, following the establishment of connections, the developmental growth capacity declines. Besides environmental challenges, this switch largely accounts for the failure of adult central nervous system (CNS) axons to regenerate. Here, we discuss the cell intrinsic control of axon regeneration, including not only the regulation of transcriptional and epigenetic mechanisms, but also the modulation of local protein translation, retrograde and anterograde axonal transport, and microtubule dynamics. We further explore the causes underlying the failure of CNS neurons to mount a vigorous regenerative response, and the paradigms demonstrating the activation of cell intrinsic axon growth programs. Finally, we present potential mechanisms to support axon regeneration, as these may represent future therapeutic approaches to promote recovery following CNS injury and disease. © 2014 The Authors.
| EMTREE drug terms: | adenylate cyclasebinding proteincaspase 3cyclic AMPguanine nucleotide exchange factorhistone deacetylase 5histone deacetylase 6khellinkinesinmammalian target of rapamycinmessenger RNAmitogen activated protein kinaseneuromodulinphosphatidylinositol 3,4,5 trisphosphate 3 phosphataseprotein kinase Bprotein kinase Cprotein p53rolipramSTAT3 proteinstress activated protein kinasesuppressor of cytokine signaling 3valproic acidvoltage gated calcium channel |
|---|---|
| EMTREE medical terms: | Caenorhabditis eleganscalcium transportcell functioncell intrinsic controlcell protectiondeacetylationelectrostimulationepigeneticsgene expressionhistone acetylationhumanmicrotubulenerve fiber growthnerve fiber regenerationnerve fiber transportnerve transectionnonhumannuclear localization signalnucleotide sequencepriority journalprotein synthesisretina ganglion cellretrograde nerve fiber transportreviewsensory nerve celltranscription initiationtranscription regulation |
| MeSH: | AnimalsAxonal TransportAxonsHumansMicrotubule ProteinsNerve Regeneration |
adenylate cyclase, 9012-42-4; caspase 3, 169592-56-7; cyclic AMP, 60-92-4; khellin, 82-02-0; mitogen activated protein kinase, 142243-02-5; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase, 210488-47-4; protein kinase B, 148640-14-6; protein kinase C, 141436-78-4; rolipram, 61413-54-5; stress activated protein kinase, 155215-87-5; valproic acid, 1069-66-5, 99-66-1
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| Office of Fuel Cycle Technologies | FCOMP-01-0124 | FCT |
| Office of Fuel Cycle Technologies | FEDER-017455 | FCT |
| Office of Fuel Cycle Technologies | HMSP-ICT/0020/2010 | FCT |
| National Institutes of Health | NS051255 | NIH |
Sousa, M.M.; Nerve Regeneration Group, Instituto de Biologia Molecular e Celular - IBMC, University of Porto, Portugal;
© Copyright 2014 Elsevier B.V., All rights reserved.